Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Diseases of the Colon and Rectum
|
September 11, 2024
Impact of the Diverting Stoma on Renal Function
Takuki Yagyu, Madoka Hamada, Masahiko Hatta, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 4, 2018
[Two Successful Cases of Surgical Treatment of Reconstructed Gastric Tube-Bronchial Fistula after Esophagectomy for Esophageal Cancer by Pedunculated Latissimus Dorsi Flap]
Hiromi Mukaide, Taku Michiura, Toshinori Kobayashi, et al.
BMJ Open Gastroenterology
|
September 26, 2017
Comparison of outcomes between symptomatic and asymptomatic patients with colorectal cancer: a propensity score-matched analysis of surgical invasiveness, medical costs and oncological outcomes
Ryo Inada, Takeshi Nagasaka, Ayako Watanabe, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 13, 2025
D3 lymph node dissection in colon cancer patients aged 90 years and over: Is it justified? A multi-institutional retrospective study
Fuminori Teraishi, Satoe Takanaga, Ryo Inada, et al.
International Journal of Colorectal Disease
|
July 8, 2020
The possibility of a transanal tube as an alternative to diverting stoma in terms of preventing severe postoperative anastomotic leakage after laparoscopic low anterior resection
Tomoko Matsumoto, Madoka Hamada, Ryo Inada, et al.
Surgical Technology International
|
May 1, 2019
Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases
Kenta Sui, Takehiro Okabayashi, Jun Iwata, et al.
Oncology Letters
|
February 14, 2018
<i>BRAF</i> V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer
Tatsuya Morikawa, Ryo Inada, Takeshi Nagasaka, et al.
Acta Medica Okayama
|
April 23, 2015
Aggressive multimodality treatment for advanced rectal cancer
Ryo Inada, Takeshi Nagasaka, Toshiaki Toshima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 7, 2015
[A case of appendix cancer treated as cancer of unknown primary origin]
Hijiri Matsumoto, Ryo Inada, Takeshi Nagasaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 7, 2015
[A successful multimodality therapy for a case of recurrent rectal cancer with KRAS mutation]
Ayako Watanabe, Ryo Inada, Takeshi Nagasaka, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Diseases of the Colon and Rectum
|
September 11, 2024
Impact of the Diverting Stoma on Renal Function
Takuki Yagyu, Madoka Hamada, Masahiko Hatta, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 4, 2018
[Two Successful Cases of Surgical Treatment of Reconstructed Gastric Tube-Bronchial Fistula after Esophagectomy for Esophageal Cancer by Pedunculated Latissimus Dorsi Flap]
Hiromi Mukaide, Taku Michiura, Toshinori Kobayashi, et al.
BMJ Open Gastroenterology
|
September 26, 2017
Comparison of outcomes between symptomatic and asymptomatic patients with colorectal cancer: a propensity score-matched analysis of surgical invasiveness, medical costs and oncological outcomes
Ryo Inada, Takeshi Nagasaka, Ayako Watanabe, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 13, 2025
D3 lymph node dissection in colon cancer patients aged 90 years and over: Is it justified? A multi-institutional retrospective study
Fuminori Teraishi, Satoe Takanaga, Ryo Inada, et al.
International Journal of Colorectal Disease
|
July 8, 2020
The possibility of a transanal tube as an alternative to diverting stoma in terms of preventing severe postoperative anastomotic leakage after laparoscopic low anterior resection
Tomoko Matsumoto, Madoka Hamada, Ryo Inada, et al.
Surgical Technology International
|
May 1, 2019
Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases
Kenta Sui, Takehiro Okabayashi, Jun Iwata, et al.
Oncology Letters
|
February 14, 2018
<i>BRAF</i> V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer
Tatsuya Morikawa, Ryo Inada, Takeshi Nagasaka, et al.
Acta Medica Okayama
|
April 23, 2015
Aggressive multimodality treatment for advanced rectal cancer
Ryo Inada, Takeshi Nagasaka, Toshiaki Toshima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 7, 2015
[A case of appendix cancer treated as cancer of unknown primary origin]
Hijiri Matsumoto, Ryo Inada, Takeshi Nagasaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 7, 2015
[A successful multimodality therapy for a case of recurrent rectal cancer with KRAS mutation]
Ayako Watanabe, Ryo Inada, Takeshi Nagasaka, et al.
Page
of 6